Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Total Liabilities
Everything the company owes to creditors and other parties.
Scholar Rock Holding CorporationNASDAQ: SRRK
Total Liabilities · Q3 FY2026 · quarter ended Sep 2026
Total liabilities rises 66.3% from a year ago
Total liabilities stood at $277.3M at the end of Q3 FY2026, up 66.3% from a year earlier and up 2.8% from the prior quarter. Over 3 fiscal years it compounded at +17.5% a year.
Context
- Total liabilities amounted to 62.2% of total assets at the end of Q3 FY2026, up 21.7 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +66.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 158.78M USD
- Year-over-year change
- +49.4%
- 4-year CAGR
- +4.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 158.78M | +49.4% |
| FY2024 | 2024-12-31 | 106.29M | +23.9% |
| FY2023 | 2023-12-31 | 85.82M | -12.4% |
| FY2022 | 2022-12-31 | 97.93M | -26.0% |
| FY2021 | 2021-12-31 | 132.37M | — |
Total Liabilities vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's Sep 2026 total liabilities of $277.3M is the 7th highest of the 11 companies compared; the peer median is $305.53M.
- Its year-over-year change of +66.3% is the 4th highest of 11, against a peer median of +15.5%.
- Total liabilities amounts to 62.2% of total assets for SRRK, versus a peer median of 26.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.72B | +30.2% | +17.3% | 305.9% | |
| Jun 2026 | $3.42B | +20.2% | +14.8% | 105.1% | |
| Sep 2026 | $2.52B | +4.3% | +15.7% | 86.5% | |
| Mar 2026 | $1.67B | -27.9% | -7.0% | 52.7% | |
| Jun 2026 | $319.19M | -7.3% | -26.4% | 23.0% | |
| Jun 2026 | $291.86M | +85.3% | +58.5% | 29.4% | |
| Sep 2026 | $277.3M | +66.3% | +17.5% | 62.2% | |
| Sep 2026 | $147.35M | +493.7% | +14.2% | 8.3% | |
| Mar 2026 | $78.01M | +91.3% | -4.6% | 18.6% | |
| Sep 2026 | $53.49M | +10.7% | +130.5% | 4.5% | |
| Mar 2026 | $48.4M | -14.8% | -2.5% | 10.9% | |
| Peer median (excluding SRRK) | $305.53M | +15.5% | +14.5% | 26.2% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 212.84M | 103.28M | 101.86M | 177.88M | 323.53M |
| Short-term Investments | 40.16M | 212.09M | 178.08M | 259.4M | 44.04M |
| Net Receivables | 0 | 2.74M | 1.08M | 2.15M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.33M | 0 | 0 | 0 | 17.58M |
| Total Current Assets | 265.32M | 328.02M | 288.19M | 451.17M | 385.15M |
| Property, Plant & Equipment (Net) | 35.01M | 25.93M | 16.02M | 18.41M | 12.09M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 4.07M | 2.4M | 0 |
| Long-term Investments | 2.5M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.62M | 4.22M | 2.75M | 2.96M | 7.04M |
| Total Non-current Assets | 39.13M | 30.14M | 22.84M | 23.76M | 19.13M |
| Total Assets | 304.45M | 358.17M | 311.04M | 474.92M | 404.27M |
| Account Payables | 4.43M | 3.99M | 3.47M | 10.1M | 10.3M |
| Short-term Debt | 8.98M | 0 | 1.33M | 0 | 5.55M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 33.19M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.13M | 222K | 85K | 0 | 19.45M |
| Total Current Liabilities | 64.3M | 36.39M | 32.74M | 46.94M | 55.42M |
| Long-term Debt | 48.42M | 49.74M | 48.68M | 50.15M | 99.71M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 68.07M | 61.54M | 53.08M | 59.35M | 103.37M |
| Total Liabilities | 132.37M | 97.93M | 85.82M | 106.29M | 158.78M |
| Common Stock | 35K | 52K | 76K | 94K | 108K |
| Retained Earnings | (376.13M) | (510.63M) | (676.42M) | (922.72M) | (1.3B) |
| Accumulated OCI | (35K) | (884K) | 92K | 160K | 94K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 172.07M | 260.24M | 225.22M | 368.63M | 245.49M |
| Total Debt | 84.47M | 69.4M | 61.82M | 65.13M | 108.92M |
| Net Debt | (128.37M) | (33.88M) | (40.04M) | (112.75M) | (214.61M) |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.